{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:26:12Z","timestamp":1791559572870,"version":"4.3.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-026-00330-3","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:02:21Z","timestamp":1787090541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early-onset, treatment-cycle-linked hyperinsulinaemic insulin resistance during capivasertib therapy: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Yosuke","family":"Motai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0353-5807","authenticated-orcid":false,"given":"Hiroaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"330_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.breast.2022.03.018","volume":"63","author":"A Andrikopoulou","year":"2022","unstructured":"Andrikopoulou A, Chatzinikolaou S, Panourgias E, Kaparelou M, Liontos M, Dimopoulos MA, Zagouri F. The emerging role of capivasertib in breast cancer. Breast. 2022;63:157\u201367.","journal-title":"Breast"},{"key":"330_CR2","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","volume":"388","author":"NC Turner","year":"2023","unstructured":"Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez HL, et al. Capivasertib in hormone receptor-positive advanced breast cancer. N Engl J Med. 2023;388:2058\u201370.","journal-title":"N Engl J Med"},{"key":"330_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169:381\u2013405.","journal-title":"Cell"},{"key":"330_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrm3351","volume":"13","author":"D Leto","year":"2012","unstructured":"Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 2012;13:383\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"330_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","volume":"156","author":"GV Rayasam","year":"2009","unstructured":"Rayasam GV, Tulasi VK, Sodhi R, Davis JA, Ray A. Glycogen synthase kinase 3: more than a namesake. Br J Pharmacol. 2009;156:885\u201398.","journal-title":"Br J Pharmacol"},{"key":"330_CR6","doi-asserted-by":"publisher","first-page":"103697","DOI":"10.1016\/j.esmoop.2024.103697","volume":"9","author":"HS Rugo","year":"2024","unstructured":"Rugo HS, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez HL, et al. Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study. ESMO Open. 2024;9:103697.","journal-title":"ESMO Open"},{"key":"330_CR7","first-page":"e63710","volume":"16","author":"YE Rodriguez","year":"2024","unstructured":"Rodriguez YE, Batra R, Patel K, Martinez S. Capivasertib-induced diabetic ketoacidosis in a patient with estrogen receptor-positive\/human epidermal growth factor receptor 2-negative metastatic breast cancer and no prior history of diabetes mellitus: a case report. Cureus. 2024;16:e63710.","journal-title":"Cureus"},{"key":"330_CR8","first-page":"e81513","volume":"17","author":"B Habeb","year":"2025","unstructured":"Habeb B, Valdes O, Khair S, Sidhu G, Fowler M. Capivasertib-induced diabetic ketoacidosis in a non-diabetic patient with metastatic prostate cancer with bone involvement: a case report of a rare but serious metabolic complication. Cureus. 2025;17:e81513.","journal-title":"Cureus"},{"key":"330_CR9","doi-asserted-by":"publisher","first-page":"luaf198","DOI":"10.1210\/jcemcr\/luaf198","volume":"3","author":"S Nicolich-Henkin","year":"2025","unstructured":"Nicolich-Henkin S, Waters L, Bansal N, Klek S. Glycemic derangements with capivasertib-from hyperglycemia to diabetic ketoacidosis: a report of 3 cases. JCEM Case Rep. 2025;3:luaf198.","journal-title":"JCEM Case Rep"},{"key":"330_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.70352\/scrj.cr.25-0514","volume":"11","author":"Y Nomoto","year":"2025","unstructured":"Nomoto Y, Mukai M, Eguchi Y, Yoshinaka H, Shinden Y, Nakajo A. A case of grade 4 hyperglycemia induced by capivasertib and successfully managed with early insulin intervention. Surg Case Rep. 2025;11:25\u20130514.","journal-title":"Surg Case Rep"},{"key":"330_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s13340-025-00841-x","volume":"16","author":"S Sasada","year":"2025","unstructured":"Sasada S, Ohno H, Taonouchi H, Teshima M, Takaya M, Fujimoto M, et al. Dynamic changes of blood glucose level during capivasertib treatment in metastatic breast cancer: a case report. Diabetol Int. 2025;16:851\u20134.","journal-title":"Diabetol Int"},{"key":"330_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00125-023-06055-7","volume":"67","author":"J Basset-Sagarminaga","year":"2024","unstructured":"Basset-Sagarminaga J, van de Weijer T, Iozzo P, Schrauwen P, Schrauwen-Hinderling VB. Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research. Diabetologia. 2024;67:407\u201319.","journal-title":"Diabetologia"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00330-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00330-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00330-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:02:22Z","timestamp":1787090542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-026-00330-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1186\/s40842-026-00330-3","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent for publication of this case report was obtained from the patient.","order":1,"name":"Ethics","label":"Ethical approval and consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"57"}}